Anti-IL-6 mAb (Vaccinex)

N/A

Report date: 2025/03/18 14:23:09

Base Information

Drug NameAnti-IL-6 mAb (Vaccinex)
Drug Alias NameAzintrelmAb-1339VX-30OPR-003OP-R003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInterleukin-6 inhibitors
TargetsInterleukin-6
Therapy Area/IndicationsArthritis, RheumatoidHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVaccinex Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A